Under pressure, biotech and pharma grapple with how to take action on climate

Under pressure, biotech and pharma grapple with how to take action on climate As the health impacts of climate change become harder to ignore, biotech and pharma companies are facing increasing pressure to reduce their carbon emissions. Erica Goode STAT

...

Globally, large public biotech and pharmaceutical companies are responsible for more than 200 million metric tons of carbon dioxide and equivalent emissions, according to estimates from one 2022 report. The bulk of those emissions are tied to companies’ products and supply chains, which can be hard to measure. In the U.S., about 8.5% of the national carbon footprint can be attributed to the health care industry at large.